These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 8402893)

  • 1. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
    Steimle V; Otten LA; Zufferey M; Mach B
    Cell; 1993 Oct; 75(1):135-46. PubMed ID: 8402893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.
    Sartoris S; Tosi G; De Lerma Barbaro A; Cestari T; Accolla RS
    Eur J Immunol; 1996 Oct; 26(10):2456-60. PubMed ID: 8898960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three novel mutations of the CIITA gene in MHC class II-deficient patients with a severe immunodeficiency.
    Dziembowska M; Fondaneche MC; Vedrenne J; Barbieri G; Wiszniewski W; Picard C; Cant AJ; Steimle V; Charron D; Alca-Loridan C; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2002 Feb; 53(10-11):821-9. PubMed ID: 11862382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). 1993.
    Steimle V; Otten LA; Zufferey M; Mach B
    J Immunol; 2007 Jun; 178(11):6677-88. PubMed ID: 17513710
    [No Abstract]   [Full Text] [Related]  

  • 5. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
    Zhou H; Su HS; Zhang X; Douhan J; Glimcher LH
    J Immunol; 1997 May; 158(10):4741-9. PubMed ID: 9144488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.
    Muhlethaler-Mottet A; Otten LA; Steimle V; Mach B
    EMBO J; 1997 May; 16(10):2851-60. PubMed ID: 9184229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.
    Bradley MB; Fernandez JM; Ungers G; Diaz-Barrientos T; Steimle V; Mach B; O'Reilly R; Lee JS
    J Immunol; 1997 Aug; 159(3):1086-95. PubMed ID: 9233601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
    Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
    Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease.
    Krawczyk M; Reith W
    Tissue Antigens; 2006 Mar; 67(3):183-97. PubMed ID: 16573555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
    J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
    J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N
    Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression.
    Peijnenburg A; Gobin SJ; van Eggermond MC; Godthelp BC; van Graafeiland N; van den Elsen PJ
    J Immunol; 1997 Sep; 159(6):2720-7. PubMed ID: 9300692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
    Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels.
    Schmetterer KG; Seidel MG; Körmöczi U; Rottal A; Schwarz K; Matthes-Martin S; Steinberger P; Pickl WF
    Int Arch Allergy Immunol; 2010; 152(4):390-400. PubMed ID: 20197681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M; Jager M; Ono SJ
    Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II transactivator suppresses transcription of thyroid-specific genes.
    Mori-Aoki A; Pietrarelli M; Nakazato M; Caturegli P; Kohn LD; Suzuki K
    Biochem Biophys Res Commun; 2000 Nov; 278(1):58-62. PubMed ID: 11071855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA; Rimsza LM; Murphy SP
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective class II transactivator expression in a B lymphoma cell line.
    Prod'homme T; Drénou B; De Ruyffelaere C; Barbieri G; Wiszniewski W; Bastard C; Charron D; Alcaide-Loridan C
    Leukemia; 2004 Apr; 18(4):832-40. PubMed ID: 14973505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.